• Users Online: 641
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Comparison of Interleukin-33 serum levels in asthmatic patients with a control group and relation with the severity of the disease

Momen Tooba, Ahanchian Hamid, Reisi Mohsen, Shamsdin Seyedeh Azra, Shahsanai Armindokht, Keivanfar Majid

Year : 2017| Volume: 8| Issue : 1 | Page no: 65-65

   This article has been cited by
 
1 The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma
Kentaro Machida,Michael Aw,Brittany M. A. Salter,Xiaotian Ju,Manali Mukherjee,Gail M. Gauvreau,Paul M. O’Byrne,Parameswaran Nair,Roma Sehmi
American Journal of Respiratory and Critical Care Medicine. 2020; 202(8): 1105
[Pubmed]  [Google Scholar] [DOI]
2 Cytokines at the Interplay Between Asthma and Atherosclerosis?
Danila Gurgone,Lucy McShane,Charles McSharry,Tomasz J. Guzik,Pasquale Maffia
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
3 IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells
David E. Ochayon,Ayad Ali,Pablo C. Alarcon,Durga Krishnamurthy,Leah C. Kottyan,Michael T. Borchers,Stephen N. Waggoner
Journal of Leukocyte Biology. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Biologics or immunotherapeutics for asthma?
Hock L. Tay,Paul S. Foster
Pharmacological Research. 2020; : 104782
[Pubmed]  [Google Scholar] [DOI]
5 Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics
Celeste M. Porsbjerg,Asger Sverrild,Clare M. Lloyd,Andrew N. Menzies-Gow,Elisabeth H. Bel
European Respiratory Journal. 2020; 56(5): 2000260
[Pubmed]  [Google Scholar] [DOI]
6 L’asthme sévère à l’ère des biothérapies
Laurent Guilleminault,Alain Didier
La Presse Médicale. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Serum levels of epithelial-derived mediators and interleukin-4/interleukin-13 signaling after bronchial challenge with Dermatophagoides pteronyssinus in patients with allergic asthma
Virginija Kalinauskaite-Zukauske,Ieva Janulaityte,Andrius Januskevicius,Kestutis Malakauskas
Scandinavian Journal of Immunology. 2019;
[Pubmed]  [Google Scholar] [DOI]
8 IL-33 in obesity: where do we go from here?
Marcos Felipe Andrade de Oliveira,André Talvani,Etel Rocha-Vieira
Inflammation Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 Determination of the Cytomegalovirus (CMV) infection Role with the Disturbances of Immunoglobulin E (IgE) and Interleukin-33 (IL-33) Concentrations in the Pathogenesis of Asthma and Atherosclerosis in a Sample of Iraqi Patients
Jasim Muhsin,Sura Yousif,Ameer Hadi,Ahmed Rawdhan
Journal of Pure and Applied Microbiology. 2019; 13(2): 1003
[Pubmed]  [Google Scholar] [DOI]
10 Regulating the development of pulmonary Group 2 innate lymphoid cells
Sofia Helfrich,Claudia U. Duerr
Biological Chemistry. 2019; 0(0)
[Pubmed]  [Google Scholar] [DOI]
11 Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection
Chae Won Kim,Hye Jee Yoo,Jang Hyun Park,Ji Eun Oh,Heung Kyu Lee
Viruses. 2019; 11(9): 840
[Pubmed]  [Google Scholar] [DOI]
12 Therapeutic antibodies: A new era in the treatment of respiratory diseases?
T. Sécher,L. Guilleminault,K. Reckamp,I. Amanam,L. Plantier,N. Heuzé-Vourcæh
Pharmacology & Therapeutics. 2018;
[Pubmed]  [Google Scholar] [DOI]
13 IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
Milica M. Borovcanin,Slavica M. Janicijevic,Ivan P. Jovanovic,Nevena Gajovic,Nebojsa N. Arsenijevic,Miodrag L. Lukic
Frontiers in Psychiatry. 2018; 9
[Pubmed]  [Google Scholar] [DOI]

 

Read this article